abstract |
The present invention provides formulations and dosage regimens of an anti-ανβ6 antibody or an ανβ6 binding fragment thereof. These formulations find use in the treatment of, for example, fibrosis (e.g., idiopathic pulmonary fibrosis), acute lung injury and acute renal injury. |